AKBA: Akebia Threapeutics Inc insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Institutional ownership (Q2 2026)
170 institutions reported holding $120.14M of Akebia Threapeutics Inc on Form 13F (171 the quarter before). 36 opened a new position and 36 sold out. Shares held by institutions: +8%.
| Largest holders | Shares | Value |
|---|---|---|
| BlackRock, Inc. | 19,986,374 | $22.78M |
| VANGUARD CAPITAL MANAGEMENT LLC | 11,322,143 | $12.91M |
| AQR CAPITAL MANAGEMENT LLC | 9,151,524 | $10.43M |
| GEODE CAPITAL MANAGEMENT, LLC | 6,727,302 | $7.67M |
| STATE STREET CORP | 5,390,853 | $6.15M |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 4,273,026 | $4.87M |
| Nantahala Capital Management, LLC | 4,000,000 | $4.56M |
| GOLDMAN SACHS GROUP INC | 3,689,167 | $4.21M |
| MILLENNIUM MANAGEMENT LLC | 3,196,605 | $3.64M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2,533,977 | $2.89M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.